Abstract
The murine MBT-2 bladder tumor model in syngeneic C3H/HeN mice was used to investigate the feasibility of gene therapy based on the delivery of interferon-γ (IFN-γ) in vivo by retroviral vectors. We constructed a recombinant retroviral vector pRUFneo/IFN-γ, which was transfected into a retroviral packaging cell line ψCRE, to produce ψCRE/pRUFneo/IFN-γ cells. The expressions of the neo and IFN-γ genes were verified by reverse transcription-polymerase chain reaction and IFN-γ was detected in the culture supernatant from ψCRE/pRUFneo/IFN-γ cells. After receiving MBT-2 cells admixed with retroviral pRUFneoIFN-γ supernatant, C3H/HeN mice exhibited lower tumor incidence, lower tumor mass, and higher survival rate, as well as higher antitumor responses compared to those injected with MBT-2 cells admixed with control retroviral supernatant. Moreover, the retroviral pRUFneoIFN-γ supernatant was able to suppress the growth of rechallenged tumors in postoperated mice. Although the IFN-γ protein secreted from ψCRE/pRUFneo/IFN-γ cells partly contributes to the antitumor effect of retroviral pRUFneoIFN-γ supernatant, the retroviruses carrying the IFN-γ gene transduced MBT-2 cells in vivo, which may result in enhancing local IFN-γ production from tumor cells. Because bladder is suitable for the intravesical instillation of therapeutic agents, in vivo administration of retroviral vectors encoding IFN-γ may be explored for the treatment of bladder cancer. Cancer Gene Therapy (2001) 8, 73–81
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shiau, AL., Lin, CY., Tzai, TS. et al. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-γ. Cancer Gene Ther 8, 73–81 (2001). https://doi.org/10.1038/sj.cgt.7700271
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700271
Keywords
This article is cited by
-
Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies
Current Respiratory Care Reports (2012)
-
Inhibition of nuclear delivery of plasmid DNA and transcription by interferon γ: hurdles to be overcome for sustained gene therapy
Gene Therapy (2011)
-
Enhancement of antitumor activity of gammaretrovirus carrying IL-12 gene through genetic modification of envelope targeting HER2 receptor: a promising strategy for bladder cancer therapy
Cancer Gene Therapy (2010)
-
Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer
Gene Therapy (2001)